Search Browse Earnings

Deciphera Pharmaceuticals, Inc. — SlamSEC

Deciphera Pharmaceuticals, Inc.

Pharmaceutical Preparations·WALTHAM, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$96.1M

+128.5% YoY

FY 2023

Adj. EBITDA

-$297.1M

-309.0% margin

FY 2023

Net Income

-$300.0M

-312.0% margin

FY 2023

EPS (Diluted)

-$5.16

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$64.7M

FY 2023

Total Debt

—

Net Cash

$64.7M

FY 2023

Enterprise Value

—

Debt / EBITDA

0.2x

FY 2023

EV / EBITDA

—

Employees

—